Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Gall Bladder Cancer Clinical Trial Report Overview
A total of 620 Gall Bladder Cancer clinical trials were conducted as of December 2023. The Gall Bladder Cancer clinical trial report provides a comprehensive understanding of the Gall Bladder Cancer clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials.
Key Regions | · Asia-Pacific
· Europe · North America · Middle East and Africa · South and Central America |
Key Countries | · United States
· China · Japan · South Korea · India · United Kingdom · Germany · Canada |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · AstraZeneca Plc
· Bristol-Myers Squibb Co · Merck & Co Inc · F. Hoffmann-La Roche Ltd · Eli Lilly and Co · Sanofi · Eisai Co Ltd · Sino Biopharmaceutical Ltd · Others |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Gall Bladder Cancer Clinical Trials Segmentation by Regions and Countries
Asia-Pacific led the Gall Bladder Cancer clinical trials landscape with more than 45% of the clinical trials conducted as of December 2023.
The key regions considered for Gall Bladder Cancer clinical trials analysis are Asia-Pacific, Europe, North America, the Middle East and Africa, and South and Central America.
In the country-wise analysis, the US had the highest number of gallbladder cancer clinical trials, as of December 2023. France had the highest average patient enrollment of gallbladder cancer clinical trials, as of December 2023.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan had the highest proportion of Gallbladder Cancer to Oncology clinical trials as of December 2023.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, India had the highest proportion of Gallbladder Cancer to Oncology clinical trials as of December 2023.
Gall Bladder Cancer Clinical Trials Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Gall Bladder Cancer Clinical Trials
Gall Bladder Cancer Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Gall Bladder Cancer clinical trials are company, institution, and the government. As of December 2023, more than 59% of Gall Bladder Cancer clinical trials conducted were sponsored by institution sponsor type, followed by the company.
Gall Bladder Cancer Clinical Trials Analysis by Sponsor Type, 2023 (%)
Buy the Full Report for More Insights into the Gall Bladder Cancer Clinical Trials Sponsor Types
Gall Bladder Cancer Clinical Trials - Competitive Landscape
In 2023, AstraZeneca Plc conducted the highest number of Gall Bladder Cancer clinical trials.
A few of the leading sponsors for Gall Bladder Cancer clinical trials are:
- AstraZeneca Plc
- Bristol-Myers Squibb Co
- Merck & Co Inc
- Hoffmann-La Roche Ltd
- Eli Lilly and Co
- Sanofi
- Eisai Co Ltd
- Sino Biopharmaceutical Ltd
Gall Bladder Cancer Clinical Trials Analysis by Leading Companies, 2023 (%)
Buy Full Report to Know More About the Leading Players of Gall Bladder Cancer Clinical Trials
Segments Covered in the Report
Gall Bladder Cancer Clinical Trials Regional Outlook (2023)
- Asia-Pacific
- Europe
- North America
- Middle East and Africa
- South and Central America
Gall Bladder Cancer Clinical Trials Country Outlook (2023)
- United States
- China
- Japan
- South Korea
- India
- United Kingdom
- Germany
- Canada
Gall Bladder Cancer Clinical Trials Sponsor Type Outlook (2023)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- Assists in formulating key investment strategies.
- Helps in identifying time-saving and cost-efficient locations to conduct clinical trials.
- Provides top-level analysis of the global clinical trials market to help in identifying key business opportunities.
- Helps in understanding trial count and enrollment trends by country in the global therapeutics market.
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials.
- Facilitates clinical trial assessment of the indication on a global, regional, and country level.
Bristol-Myers Squibb Co
Merck & Co Inc
F. Hoffmann-La Roche Ltd
Eli Lilly and Co
Sanofi
Eisai Co Ltd
Sino Biopharmaceutical Ltd
Aslan Pharmaceuticals Ltd
C. H. Boehringer Sohn AG & Co KG
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Gall Bladder Cancer clinical trials in December 2023?
Asia-Pacific accounted for the highest number of Gall Bladder Cancer clinical trials as of December 2023.
-
Which country conducted the highest number of Gall Bladder Cancer clinical trials?
The US conducted the highest number of Gall Bladder Cancer clinical trials as of December 2023.
-
Which sponsor type was the most prominent in the Gall Bladder Cancer clinical trials?
As of December 2023, most of the Gall Bladder Cancer clinical trials conducted were sponsored by institution sponsor type.
-
Who are the leading sponsors of Gall Bladder Cancer clinical trials?
A few of the leading sponsors of Gall Bladder Cancer clinical trials are AstraZeneca Plc, Bristol-Myers Squibb Co, Merck & Co Inc, F. Hoffmann-La Roche Ltd, Eli Lilly and Co, Sanofi, Eisai Co Ltd, and Sino Biopharmaceutical Ltd among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.